Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.

Bruna J, Argyriou AA, Anastopoulou GG, Alemany M, Nadal E, Kalofonou F, Piulats JM, Simó M, Velasco R, Kalofonos HP.

J Peripher Nerv Syst. 2020 Mar 12. doi: 10.1111/jns.12371. [Epub ahead of print]

PMID:
32166812
2.

[Historical perspective of the studies with the greatest impact on the treatment of gliomas].

Bruna J, Alemany M.

Rev Neurol. 2020 Mar 16;70(6):220-230. doi: 10.33588/rn.7006.2019144. Review. Spanish.

3.

Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies.

Calls A, Carozzi V, Navarro X, Monza L, Bruna J.

Exp Neurol. 2020 Mar;325:113141. doi: 10.1016/j.expneurol.2019.113141. Epub 2019 Dec 19. Review.

PMID:
31865195
4.

Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.

Bruna J, Alberti P, Calls-Cobos A, Caillaud M, Damaj MI, Navarro X.

Exp Neurol. 2020 Mar;325:113154. doi: 10.1016/j.expneurol.2019.113154. Epub 2019 Dec 15. Review.

PMID:
31837318
5.

Voltage-gated sodium channel dysfunction and the search for other satellite channels in relation to acute oxaliplatin-induced peripheral neurotoxicity.

Argyriou AA, Park SB, Bruna J, Cavaletti G.

J Peripher Nerv Syst. 2019 Dec;24(4):360-361. doi: 10.1111/jns.12354. Epub 2019 Nov 7. No abstract available.

PMID:
31696990
6.

Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment.

Velasco R, Alberti P, Bruna J, Psimaras D, Argyriou AA.

J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S52-S62. doi: 10.1111/jns.12338. Review.

PMID:
31647153
7.

Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Cayuela N, Jaramillo-Jiménez E, Càmara E, Majós C, Vidal N, Lucas A, Gil-Gil M, Graus F, Bruna J, Simó M.

Neuro Oncol. 2019 Nov 4;21(11):1470-1479. doi: 10.1093/neuonc/noz130.

PMID:
31549152
8.

Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.

Argyriou AA, Antonacopoulou AG, Alberti P, Briani C, Bruna J, Velasco R, Anastopoulou GG, Park SB, Cavaletti G, Kalofonos HP.

J Peripher Nerv Syst. 2019 Dec;24(4):298-303. doi: 10.1111/jns.12347. Epub 2019 Oct 16.

PMID:
31486252
9.

Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatment.

Psimaras D, Velasco R, Birzu C, Tamburin S, Lustberg M, Bruna J, Argyriou AA.

J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S74-S85. doi: 10.1111/jns.12339. Review.

PMID:
31393660
10.

Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity.

Argyriou AA, Bruna J, Anastopoulou GG, Velasco R, Litsardopoulos P, Kalofonos HP.

Support Care Cancer. 2020 Apr;28(4):1991-1995. doi: 10.1007/s00520-019-05023-5. Epub 2019 Aug 5.

PMID:
31378844
11.

Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings.

Argyriou AA, Park SB, Islam B, Tamburin S, Velasco R, Alberti P, Bruna J, Psimaras D, Cavaletti G, Cornblath DR; Toxic Neuropathy Consortium (TNC).

J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1361-1369. doi: 10.1136/jnnp-2019-320969. Epub 2019 Jun 29. Review.

PMID:
31256000
12.

Antifungal and physicochemical properties of inclusion complexes based on β-cyclodextrin and essential oil derivatives.

Herrera A, Rodríguez FJ, Bruna JE, Abarca RL, Galotto MJ, Guarda A, Mascayano C, Sandoval-Yáñez C, Padula M, Felipe FRS.

Food Res Int. 2019 Jul;121:127-135. doi: 10.1016/j.foodres.2019.03.026. Epub 2019 Mar 14.

PMID:
31108733
13.

Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases.

Ponce S, Bruna J, Juan O, López R, Navarro A, Ortega AL, Puente J, Verger E, Bartolomé A, Nadal E.

Crit Rev Oncol Hematol. 2019 Jun;138:190-206. doi: 10.1016/j.critrevonc.2019.03.017. Epub 2019 Apr 3. Review.

PMID:
31092376
14.

Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age.

Castet F, Alanya E, Vidal N, Izquierdo C, Mesia C, Ducray F, Gil-Gil M, Bruna J.

J Neurooncol. 2019 Jul;143(3):515-523. doi: 10.1007/s11060-019-03183-2. Epub 2019 May 3.

PMID:
31054099
15.

Wild boar (Sus scrofa) increases species diversity of semidry grassland: Field experiment with simulated soil disturbances.

Horčičková E, Brůna J, Vojta J.

Ecol Evol. 2019 Feb 5;9(5):2765-2774. doi: 10.1002/ece3.4950. eCollection 2019 Mar.

16.

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Cornblath DR, Merkies ISJ, Postma TJ, Rossi E, Alberti P, Bruna J, Argyriou AA, Briani C, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Faber CG, Lalisang RI, Brandsma D, Koeppen S, Kerrigan S, Schenone A, Grisold W, Mazzeo A, Padua L, Dorsey SG, Penas-Prado M, Valsecchi MG; CI-PeriNomS Group.

J Peripher Nerv Syst. 2019 Mar;24(1):111-119. doi: 10.1111/jns.12306. Epub 2019 Feb 8.

PMID:
30672664
17.

Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain.

Alé A, Argyriou AA, Bruna J.

Ann Transl Med. 2018 Nov;6(Suppl 1):S78. doi: 10.21037/atm.2018.10.53. No abstract available.

18.

Corrigendum.

Cayuela N, Jaramillo-Jiménez E, Majós C, Velasco R, Boget T, Graus F, Bruna J, Simó M.

Neuro Oncol. 2018 Nov 20. doi: 10.1093/neuonc/noy179. [Epub ahead of print] No abstract available.

PMID:
30462315
19.

Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations.

Izquierdo C, Barritault M, Poncet D, Cartalat S, Joubert B, Bruna J, Jouanneau E, Guyotat J, Vasiljevic A, Fenouil T, Berthezène Y, Honnorat J, Meyronet D, Ducray F.

Neurosurgery. 2019 Sep 1;85(3):E448-E456. doi: 10.1093/neuros/nyy513.

PMID:
30407589
20.

Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.

Besora S, Santos C, Izquierdo C, Martinez-Villacampa MM, Bruna J, Velasco R.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1793-1801. doi: 10.1007/s00432-018-2691-8. Epub 2018 Jun 28.

PMID:
29955956
21.

Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain.

Argyriou AA, Anastopoulou GG, Bruna J.

Ann Transl Med. 2018 Apr;6(7):127. doi: 10.21037/atm.2018.01.23. No abstract available.

22.

Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy.

Bruna J, Velasco R.

Neural Regen Res. 2018 May;13(5):775-778. doi: 10.4103/1673-5374.232459.

23.

Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.

Martínez-Villacampa M, Tavera SB, Vivas CS, Izquierdo C, Bruna J, Velasco R.

Ann Oncol. 2018 Jun;29 Suppl 5:v69. doi: 10.1093/annonc/mdy151.245. Epub 2020 Jan 7. No abstract available.

24.

Syndrome and outcome of antibody-negative limbic encephalitis.

Graus F, Escudero D, Oleaga L, Bruna J, Villarejo-Galende A, Ballabriga J, Barceló MI, Gilo F, Popkirov S, Stourac P, Dalmau J.

Eur J Neurol. 2018 Aug;25(8):1011-1016. doi: 10.1111/ene.13661. Epub 2018 May 21. Erratum in: Eur J Neurol. 2018 Oct;25(10):1303.

25.

Autonomic nervous system and cancer.

Simó M, Navarro X, Yuste VJ, Bruna J.

Clin Auton Res. 2018 Jun;28(3):301-314. doi: 10.1007/s10286-018-0523-1. Epub 2018 Mar 28. Review.

PMID:
29594605
26.

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Alberti P, Rossi E, Argyriou AA, Kalofonos HP, Briani C, Cacciavillani M, Campagnolo M, Bruna J, Velasco R, Cazzaniga ME, Cortinovis D, Valsecchi MG, Cavaletti G.

Support Care Cancer. 2018 Sep;26(9):3143-3151. doi: 10.1007/s00520-018-4170-9. Epub 2018 Mar 29.

PMID:
29594485
27.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

28.

Performance monitoring in lung cancer patients pre- and post-chemotherapy using fine-grained electrophysiological measures.

Simó M, Gurtubay-Antolin A, Vaquero L, Bruna J, Rodríguez-Fornells A.

Neuroimage Clin. 2017 Dec 28;18:86-96. doi: 10.1016/j.nicl.2017.12.032. eCollection 2018.

29.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z.

JAMA. 2017 Dec 19;318(23):2306-2316. doi: 10.1001/jama.2017.18718. Erratum in: JAMA. 2018 May 1;319(17):1824.

30.

Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.

Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.

J Neurooncol. 2018 Feb;136(3):533-539. doi: 10.1007/s11060-017-2677-4. Epub 2017 Nov 15.

PMID:
29143276
31.

Seizure-susceptible brain regions in glioblastoma: identification of patients at risk.

Cayuela N, Simó M, Majós C, Rifà-Ros X, Gállego Pérez-Larraya J, Ripollés P, Vidal N, Miró J, Gil F, Gil-Gil M, Plans G, Graus F, Bruna J.

Eur J Neurol. 2018 Feb;25(2):387-394. doi: 10.1111/ene.13518. Epub 2017 Dec 11.

PMID:
29115706
32.

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.

Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C, Kalofonos HP, Cortinovis D, Sust M, Vaqué A, Klein T, Plata-Salamán C.

Neurotherapeutics. 2018 Jan;15(1):178-189. doi: 10.1007/s13311-017-0572-5.

33.

Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.

Velasco R, Navarro X, Gil-Gil M, Herrando-Grabulosa M, Calls A, Bruna J.

J Pain Symptom Manage. 2017 Dec;54(6):815-825. doi: 10.1016/j.jpainsymman.2017.04.021. Epub 2017 Aug 8.

PMID:
28797868
34.

Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.

Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS, Kanwar R, Ambulos N, Cavaletti G, Bruna J, Briani C, Argyriou AA, Kalofonos HP, Yerges-Armstrong LM, Dorsey SG.

J Pain Symptom Manage. 2017 Nov;54(5):701-706.e1. doi: 10.1016/j.jpainsymman.2017.07.033. Epub 2017 Jul 23.

35.

Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.

Argyriou AA, Bruna J, Genazzani AA, Cavaletti G.

Nat Rev Neurol. 2017 Aug;13(8):492-504. doi: 10.1038/nrneurol.2017.88. Epub 2017 Jun 30. Review.

PMID:
28664909
36.

Timing Is Important: Unmanned Aircraft vs. Satellite Imagery in Plant Invasion Monitoring.

Müllerová J, Brůna J, Bartaloš T, Dvořák P, Vítková M, Pyšek P.

Front Plant Sci. 2017 May 31;8:887. doi: 10.3389/fpls.2017.00887. eCollection 2017.

37.

Brain functional connectivity in lung cancer population: an exploratory study.

Simó M, Rifà-Ros X, Vaquero L, Ripollés P, Cayuela N, Jové J, Navarro A, Cardenal F, Bruna J, Rodríguez-Fornells A.

Brain Imaging Behav. 2018 Apr;12(2):369-382. doi: 10.1007/s11682-017-9697-8.

PMID:
28290076
38.

Life and death of Picea abies after bark-beetle outbreak: ecological processes driving seedling recruitment.

Macek M, Wild J, Kopecký M, Červenka J, Svoboda M, Zenáhlíková J, Brůna J, Mosandl R, Fischer A.

Ecol Appl. 2017 Jan;27(1):156-167. doi: 10.1002/eap.1429.

PMID:
28052495
39.

Preradiotherapy MR Imaging: A Prospective Pilot Study of the Usefulness of Performing an MR Examination Shortly before Radiation Therapy in Patients with Glioblastoma.

Majós C, Cos M, Castañer S, Pons A, Gil M, Fernández-Coello A, Macià M, Bruna J, Aguilera C.

AJNR Am J Neuroradiol. 2016 Dec;37(12):2224-2230. Epub 2016 Sep 8.

40.

An assessment of lactobiopolymer-montmorillonite composites for dip coating applications on fresh strawberries.

Junqueira-Gonçalves MP, Salinas GE, Bruna JE, Niranjan K.

J Sci Food Agric. 2017 Apr;97(6):1846-1853. doi: 10.1002/jsfa.7985. Epub 2016 Sep 5.

PMID:
27491506
41.

Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.

Velasco R, Santos C, Soler G, Gil-Gil M, Pernas S, Galan M, Palmero R, Bruna J.

J Peripher Nerv Syst. 2016 Sep;21(3):134-41. doi: 10.1111/jns.12177.

PMID:
27282616
42.

Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model.

Alé A, Bruna J, Calls A, Karamita M, Haralambous S, Probert L, Navarro X, Udina E.

Neurotoxicology. 2016 Jul;55:58-64. doi: 10.1016/j.neuro.2016.05.004. Epub 2016 May 19.

PMID:
27211850
43.

A Mathematical Motivation for Complex-Valued Convolutional Networks.

Tygert M, Bruna J, Chintala S, LeCun Y, Piantino S, Szlam A.

Neural Comput. 2016 May;28(5):815-25. doi: 10.1162/NECO_a_00824. Epub 2016 Feb 18.

PMID:
26890348
44.

Longitudinal Brain Changes Associated with Prophylactic Cranial Irradiation in Lung Cancer.

Simó M, Vaquero L, Ripollés P, Gurtubay-Antolin A, Jové J, Navarro A, Cardenal F, Bruna J, Rodríguez-Fornells A.

J Thorac Oncol. 2016 Apr;11(4):475-86. doi: 10.1016/j.jtho.2015.12.110. Epub 2016 Jan 22.

45.

An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.

Sánchez-Osuna M, Martínez-Escardó L, Granados-Colomina C, Martínez-Soler F, Pascual-Guiral S, Iglesias-Guimarais V, Velasco R, Plans G, Vidal N, Tortosa A, Barcia C, Bruna J, Yuste VJ.

Neuro Oncol. 2016 Jul;18(7):950-61. doi: 10.1093/neuonc/nov315. Epub 2016 Jan 10.

46.

Characterization of beta-cyclodextrin inclusion complexes containing an essential oil component.

Abarca RL, Rodríguez FJ, Guarda A, Galotto MJ, Bruna JE.

Food Chem. 2016 Apr 1;196:968-75. doi: 10.1016/j.foodchem.2015.10.023. Epub 2015 Oct 8.

PMID:
26593579
47.

Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature.

Izquierdo C, Velasco R, Vidal N, Sánchez JJ, Argyriou AA, Besora S, Graus F, Bruna J.

Neuro Oncol. 2016 May;18(5):707-15. doi: 10.1093/neuonc/nov197. Epub 2015 Sep 27. Review.

48.

Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.

Majós C, Cos M, Castañer S, Gil M, Plans G, Lucas A, Bruna J, Aguilera C.

Eur Radiol. 2016 Apr;26(4):1048-55. doi: 10.1007/s00330-015-3914-x. Epub 2015 Jul 19.

PMID:
26188660
49.

Brain damage following prophylactic cranial irradiation in lung cancer survivors.

Simó M, Vaquero L, Ripollés P, Jové J, Fuentes R, Cardenal F, Rodríguez-Fornells A, Bruna J.

Brain Imaging Behav. 2016 Mar;10(1):283-95. doi: 10.1007/s11682-015-9393-5.

PMID:
26015269
50.

Sedative premedication before surgery--A multicentre randomized study versus placebo.

Beydon L, Rouxel A, Camut N, Schinkel N, Malinovsky JM, Aveline C, Marret E, Bildea A, Dupoiron D, Liu N, Daniel V, Darsonval A, Chrétien JM, Rault L, Bruna J, Alberti C.

Anaesth Crit Care Pain Med. 2015 Jun;34(3):165-71. doi: 10.1016/j.accpm.2015.01.005. Epub 2015 May 23.

PMID:
26004882

Supplemental Content

Support Center